{"content":"<li class=\"n-box-item date-title\" data-end=\"1498622399\" data-start=\"1498536000\" data-txt=\"Monday, December 23, 2019\">Tuesday, June 27, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3275893\" data-ts=\"1498605661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNC\" target=\"_blank\">ARNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275893-arconic-is-s-and-ps-back-to-back-biggest-loserminus-17-in-two-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arconic is S&amp;P&#39;s back-to-back biggest loser, -17% in two days</a></h4><ul>     <li>Arconic (NYSE:<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>) owns the dubious distinction of being the <a href=\"http://www.barrons.com/articles/the-biggest-loser-arconic-tumblesagain-1498595074\" target=\"_blank\">S&amp;P 500's worst performing stock for a second straight day</a>, plunging another 9% in today's trade after tumbling 6% yesterday on the fallout from its <a href=\"https://seekingalpha.com/news/3275389-reuters-arconic-linked-grenfell-blaze\" target=\"_blank\">connection to last week's fatal high-rise fire</a> in London and <a href=\"https://seekingalpha.com/news/3275531-arconic-stop-sales-cladding-material-used-grenfell-tower\" target=\"_blank\">discontinuing global sales</a> of Reynobond PE for use in high-rise applications.</li>     <li>Morgan Stanley says it is not about to buy the dip given limited information concerning the likely legal implications behind the incident, believing it is best to remain on the sidelines until there is more clarity on the potential outcomes.</li><li>The firm worries the fallout could be \"just the beginning\" and could stall or alter the hiring of a new CEO as the board may have to shift its focus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275893\" data-linked=\"Arconic is S&amp;P&#39;s back-to-back biggest loser, -17% in two days\" data-tweet=\"$ARNC - Arconic is S&amp;P&#39;s back-to-back biggest loser, -17% in two days https://seekingalpha.com/news/3275893-arconic-is-s-and-ps-back-to-back-biggest-loserminus-17-in-two-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3275893-arconic-is-s-and-ps-back-to-back-biggest-loserminus-17-in-two-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275884\" data-ts=\"1498599510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275884-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+2.5%</font>. ETP <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/EOCC-OLD' title='Enel Generacion Chile S.A.'>EOCC-OLD</a> <font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='green'>+1.6%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a> <font color='red'>-7.7%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/BLL' title='Ball Corporation'>BLL</a> <font color='red'>-2.5%</font>. <a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a> <font color='red'>-1.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275884\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ARRY $ET $MRVL - After Hours Gainers / Losers https://seekingalpha.com/news/3275884-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3275884-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275883\" data-ts=\"1498599169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMT\" target=\"_blank\">AMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275883-american-tower-prices-750m-in-debt-to-repay-revolver\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Tower prices $750M in debt to repay revolver</a></h4><ul>    <li>American Tower (<a href=\"http://seekingalpha.com/symbol/AMT\" target=\"_blank\">AMT</a> <font color='green'>+2.5%</font>) has <a href=\"https://seekingalpha.com/pr/16873812-american-tower-corporation-prices-senior-notes-offering\" target=\"_blank\">priced a $750M offering</a> of senior debt.</li>    <li>The company's placing that amount in senior unsecured notes due 2027, bearing interest at 3.55%/year. They're being issue at 99.773% of face value.</li>    <li>Net proceeds of about $741.8M will repay outstanding indebtedness under its senior unsecured revolving facility.</li>    <li>Joint book-runners are Barclays Capital, Mizuho Securities USA, RBC Capital Markets, Santander Investment Securities and TD Securities.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275883\" data-linked=\"American Tower prices $750M in debt to repay revolver\" data-tweet=\"$AMT - American Tower prices $750M in debt to repay revolver https://seekingalpha.com/news/3275883-american-tower-prices-750m-in-debt-to-repay-revolver?source=tweet\" data-url=\"https://seekingalpha.com/news/3275883-american-tower-prices-750m-in-debt-to-repay-revolver\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275882\" data-ts=\"1498598620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275882-kb-home-rises-after-topping-earnings-revenue-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home rises after topping earnings, revenue estimates</a></h4><ul><li>KB&nbsp;Home (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>) <font color='green'>+1.6%</font>&nbsp;AH after posting solid <a href=\"https://seekingalpha.com/news/3275857-kb-home-beats-0_07-beats-revenue\" target=\"_blank\">FQ2 earnings</a> and revenue beats, and saying the housing market recovery continues on a steady path, supported by favorable industry fundamentals.</li><li>KBH says Q2 homebuilding revenues totaled $1B, beating guidance of $880M-$940M, with housing gross profit margin excluding  inventory-related charges of 16%, beating guidance of 15.6% but below 15.9% in the year-ago quarter.</li><li>Q2 deliveries rose 11% to 2,580 homes, with double-digit increases in three  of the company's four regions; the average selling price increased 11% to  $385.9K.</li><li>Net order value climbed 15% to $1.38B on a 5% rise in net orders  to 3,416, primarily reflecting strength in the west coast and southwest regions.</li><li>Ending backlog value rose 19% to $2.18B, with homes in backlog up  8% to 5,612 and the average selling price of those homes rising 11%.</li><li><a href=\"http://files.shareholder.com/downloads/KBH/4717294093x0x947802/4AC19E53-A8D9-4E6F-B4B7-9D912A189ECB/KBH_Q2_IR_Presentation_06-27-2017.pdf\" target=\"_blank\">Q2 investor presentation</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275882\" data-linked=\"KB Home rises after topping earnings, revenue estimates\" data-tweet=\"$KBH - KB Home rises after topping earnings, revenue estimates https://seekingalpha.com/news/3275882-kb-home-rises-after-topping-earnings-revenue-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3275882-kb-home-rises-after-topping-earnings-revenue-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275873\" data-ts=\"1498596250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NERV\" target=\"_blank\">NERV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275873-minerva-readies-5m-share-stock-offering-shares-off-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Minerva readies 5M-share stock offering; shares off 3% after hours</a></h4><ul><li>Minerva Neurosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a>) slips&nbsp;<font color='red'>3%</font>&nbsp;after hours on light volume after the company <a href=\"https://seekingalpha.com/pr/16873722-minerva-neurosciences-inc-offer-common-shares\" target=\"_blank\">announced </a>a public offering of 5M shares of common stock. Price and terms have yet to be announced. Net proceeds will fund clinical trials, working capital and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275873\" data-linked=\"Minerva readies 5M-share stock offering; shares off 3% after hours\" data-tweet=\"$NERV - Minerva readies 5M-share stock offering; shares off 3% after hours https://seekingalpha.com/news/3275873-minerva-readies-5m-share-stock-offering-shares-off-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3275873-minerva-readies-5m-share-stock-offering-shares-off-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275862\" data-ts=\"1498594474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SB\" target=\"_blank\">SB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275862-safe-bulkers-on-move-after-russell-3000-inclusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Safe Bulkers on the move after  Russell 3000 inclusion</a></h4><ul> <li>Safe Bulkers (NYSE:<a href='https://seekingalpha.com/symbol/SB' title='Safe Bulkers Inc.'>SB</a>) announces that the company was added to the Russell 3000 Index as part of Russell indexes annual reconstitution.</li> <li>\"We are very pleased to be included in the Russell 3000 Index as it provides us with increased visibility within the investment community,\" states Safe Bulkers President Dr. Loukas Barmparis.</li><li>Shares of Safe Bulkers&nbsp;<font color='green'>+4.07%</font>&nbsp;AH to $2.30.</li>  <li>Source: <a href=\"https://seekingalpha.com/pr/16873707-safe-bulkers-inc-added-russell-3000-index\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275862\" data-linked=\"Safe Bulkers on the move after  Russell 3000 inclusion\" data-tweet=\"$SB - Safe Bulkers on the move after Russell 3000 inclusion https://seekingalpha.com/news/3275862-safe-bulkers-on-move-after-russell-3000-inclusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3275862-safe-bulkers-on-move-after-russell-3000-inclusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275860\" data-ts=\"1498594287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVAV\" target=\"_blank\">AVAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275860-aerovironment-beats-0_27-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AeroVironment beats by $0.27, beats on revenue</a></h4><ul><li>AeroVironment (NASDAQ:<a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a>): Q4 EPS of $1.30 <font color='green'>beats by $0.27</font>.</li><li>Revenue of $125.38M (+47.9% Y/Y) <font color='green'>beats by $2.48M</font>.</li><li>Shares <font color='green'>+3.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16873720-aerovironment-inc-announces-fiscal-2017-fourth-quarter-full-year-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275860\" data-linked=\"AeroVironment beats by $0.27, beats on revenue\" data-tweet=\"$AVAV - AeroVironment beats by $0.27, beats on revenue https://seekingalpha.com/news/3275860-aerovironment-beats-0_27-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3275860-aerovironment-beats-0_27-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275857\" data-ts=\"1498593961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275857-kb-home-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home beats by $0.07, beats on revenue</a></h4><ul><li>KB Home (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>): Q2 EPS of $0.33 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $1B (+23.3% Y/Y) <font color='green'>beats by $72.57M</font>.</li><li>Shares <font color='green'>+2.4%</font>.</li><li><a href='https://seekingalpha.com/pr/16873702-kb-home-reports-2017-second-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275857\" data-linked=\"KB Home beats by $0.07, beats on revenue\" data-tweet=\"$KBH - KB Home beats by $0.07, beats on revenue https://seekingalpha.com/news/3275857-kb-home-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3275857-kb-home-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275856\" data-ts=\"1498593926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCOM\" target=\"_blank\">JCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275856-j2-global-closes-placement-of-650m-in-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J2 Global closes placement of $650M in debt</a></h4><ul>   <li>J2 Global (<a href=\"http://seekingalpha.com/symbol/JCOM\" target=\"_blank\">JCOM</a> <font color='red'>-2.7%</font>) has wrapped an <a href=\"https://seekingalpha.com/pr/16873686-j2-global-completes-private-placement-650-million-senior-unsecured-notes\" target=\"_blank\">issuance of $650M in notes</a>.</li>    <li>The debt went via private placement of 6% senior notes due 2025.</li>    <li>Net proceeds of about $636.4M will go toward redeeming all of the company's outstanding 8% senior notes due 2020, as well as to pay off all amounts outstanding under its credit facility. Any remainder goes to general purposes (which could include acquisitions).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275856\" data-linked=\"J2 Global closes placement of $650M in debt\" data-tweet=\"$JCOM - J2 Global closes placement of $650M in debt https://seekingalpha.com/news/3275856-j2-global-closes-placement-of-650m-in-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3275856-j2-global-closes-placement-of-650m-in-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275848\" data-ts=\"1498591526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275848-vale-shareholders-approve-corporate-reorganization\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale shareholders approve corporate reorganization</a></h4><ul>     <li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+1.7%</font>) is higher after shareholders <a href=\"http://www.reuters.com/article/us-vale-sa-equity-idUSKBN19I2K7\" target=\"_blank\">approve a share conversion plan</a> in an attempt to improve transparency, give equal votes to all shares and perhaps limit government meddling.</li>     <li>Shareholders approve all seven items on the corporate restructuring agenda, in a first step toward giving the company dispersed share ownership where no major shareholder controls decision making.</li>     <li>Investors hope the changes will help improve investor perceptions of Vale, translating into a faster convergence of share prices to those of rivals, and a decline in the miner's cost of capital.</li>     <li><a href=\"http://www.barrons.com/articles/brazil-etf-sinks-after-temer-charged-vale-rises-on-stock-consolidation-1498589029\" target=\"_blank\">Most Brazilian stocks are lower</a> following news overnight that federal prosecutors <a href=\"https://seekingalpha.com/news/3275630-crisis-brazil-deepens\" target=\"_blank\">charged Pres. Temer with corruption</a>; Brazil's benchmark interest rate surged 14 bps to 10.78%.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a>, <a href='https://seekingalpha.com/symbol/BRF' title='VanEck Vectors Brazil Small-Cap ETF'>BRF</a>, <a href='https://seekingalpha.com/symbol/BRZU' title='Direxion Daily Brazil Bull 3x Shares ETF'>BRZU</a>, <a href='https://seekingalpha.com/symbol/BZQ' title='ProShares UltraShort MSCI Brazil Capped ETF'>BZQ</a>, <a href='https://seekingalpha.com/symbol/EWZS' title='iShares MSCI Brazil Small-Cap ETF'>EWZS</a>, <a href='https://seekingalpha.com/symbol/BRAQ' title='Global X Brazil Consumer ETF'>BRAQ</a>, <a href='https://seekingalpha.com/symbol/UBR' title='ProShares Ultra MSCI Brazil Capped ETF'>UBR</a>, <a href='https://seekingalpha.com/symbol/BRAZ' title='Global X Brazil Mid-Cap ETF'>BRAZ</a>, <a href='https://seekingalpha.com/symbol/DBBR' title='Deutsche X-trackers MSCI Brazil Hedged Equity ETF'>DBBR</a>, <a href='https://seekingalpha.com/symbol/FBZ' title='First Trust Brazil AlphaDEX ETF'>FBZ</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3275848\" data-linked=\"Vale shareholders approve corporate reorganization\" data-tweet=\"$VALE $VALE $EWZ - Vale shareholders approve corporate reorganization https://seekingalpha.com/news/3275848-vale-shareholders-approve-corporate-reorganization?source=tweet\" data-url=\"https://seekingalpha.com/news/3275848-vale-shareholders-approve-corporate-reorganization\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275845\" data-ts=\"1498590879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGRX\" target=\"_blank\">AGRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275845-agile-resubmits-nda-for-contraceptive-patch-twirla-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agile resubmits NDA for contraceptive patch Twirla; shares up 2%</a></h4><ul><li>Agile Therapeutics (<a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a> <font color='green'>+1.8%</font>) <a href=\"https://seekingalpha.com/pr/16872734-agile-therapeutics-resubmits-new-drug-application-nda-transdermal-contraceptive-patch-twirla\" target=\"_blank\">resubmits </a>its New Drug Application &#40;NDA&#41; to the FDA seeking approval of lead product candidate Twirla, a low-dose combined hormonal contraceptive patch. It received a CRL in February 2013 citing the need for an additional clinical trial and additional information on the manufacturing process.</li><li>The company says it expects a six-month review once the agency accepts the filing.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256554-agile-therapeutics-announces-results-pre-submission-meeting-fda\" target=\"_blank\">Agile Therapeutics announces results of its pre-submission meeting with FDA</a> (April 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233244-agiles-positive-late-stage-trial-data-contraceptive-patch-twirla-aint-positive-shares-plummet\" target=\"_blank\">Agile's \"positive\" late-stage trial data for contraceptive patch Twirla ain't so positive; shares plummet 74% after hours</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3275845\" data-linked=\"Agile resubmits NDA for contraceptive patch Twirla; shares up 2%\" data-tweet=\"$AGRX - Agile resubmits NDA for contraceptive patch Twirla; shares up 2% https://seekingalpha.com/news/3275845-agile-resubmits-nda-for-contraceptive-patch-twirla-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3275845-agile-resubmits-nda-for-contraceptive-patch-twirla-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275844\" data-ts=\"1498590464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275844-facebook-crosses-2-billion-user-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook crosses 2 billion-user line</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='red'>-1.6%</font>) has <a href=\"http://www.investors.com/news/technology/facebook-2-billion-served-and-counting-as-milestone-reached/\" target=\"_blank\">crested 2 billion monthly active users</a>, after drawing to 1.94B MAUs in its <a href=\"https://seekingalpha.com/news/3263001-facebook-beats-q1-report-nears-2b-monthly-users\" target=\"_blank\">Q1 earnings report</a>.</li>    <li>That represents a doubling of its user base in just the past five years, since it went public in May 2012 (and hit 1B users in October of that year).</li>    <li>It's the latest of a few metric milestones for the company, which celebrated 250M <a href=\"https://seekingalpha.com/news/3274534-instagram-stories-hits-250m-daily-users-snap-minus-2_9-percent\" target=\"_blank\">daily users of Instagram Stories</a> last week, and Instagram overall <a href=\"https://seekingalpha.com/news/3259984-accelerating-growth-instagram-hits-700m-users\" target=\"_blank\">hitting 700M MAUs in April</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275844\" data-linked=\"Facebook crosses 2 billion-user line\" data-tweet=\"$FB - Facebook crosses 2 billion-user line https://seekingalpha.com/news/3275844-facebook-crosses-2-billion-user-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3275844-facebook-crosses-2-billion-user-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275843\" data-ts=\"1498590222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275843-energy-materials-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/DWSN' title='Dawson Geophysical Company'>DWSN</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275843\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$ZN $CIE $CRR - Energy/Materials - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3275843-energy-materials-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3275843-energy-materials-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275841\" data-ts=\"1498590174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIII\" target=\"_blank\">AIII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275841-acre-realty-to-liquidate-shares-down-34\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACRE Realty to liquidate; shares down 34%</a></h4><ul><li>After consideration of strategic options,<a href=\"https://seekingalpha.com/pr/16873566-acre-realty-investors-inc-announces-board-approval-dissolution\" target=\"_blank\"> the board has decided</a> to dissolve the company and the board, liquidate all assets, and distribute what's left to the shareholders.</li><li>The one land asset is known as the Highway 20 property, and it's under contract to be sold for $4.725M. Closing should take place tomorrow. The company also had $15.2M of cash and cash equivalents as of May 31.</li><li><a href='https://seekingalpha.com/symbol/AIII' title='ACRE Realty Investors Inc.'>AIII</a>&nbsp;<font color='red'>-34%</font>&nbsp;to $0.73.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275841\" data-linked=\"ACRE Realty to liquidate; shares down 34%\" data-tweet=\"$AIII - ACRE Realty to liquidate; shares down 34% https://seekingalpha.com/news/3275841-acre-realty-to-liquidate-shares-down-34?source=tweet\" data-url=\"https://seekingalpha.com/news/3275841-acre-realty-to-liquidate-shares-down-34\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275837\" data-ts=\"1498590059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275837-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/AUO' title='AU Optronics Corp.'>AUO</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/XPLR' title='Xplore Technologies Corp.'>XPLR</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SYX' title='Systemax Inc.'>SYX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275837\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$APDN $SMSI $AUO - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3275837-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3275837-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275836\" data-ts=\"1498589760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARX\" target=\"_blank\">RARX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275836-ra-pharma-selloff-buying-opportunity-jefferies-shares-down-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ra Pharma selloff a buying opportunity - Jefferies; shares down 20%</a></h4><ul><li>On the lighter side, Jefferies analyst Eun Yang says the selling in Ra Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <font color='red'>-19.7%</font>) after it released mid-stage data on PNH candidate RA101495 not only ain't no big thing, but is a buying opportunity. She says the softness \"may not necessarily be data-related\" but on the lack of near-term catalysts until the next data readout at year-end. Ms. Yang is apparently ignoring the fact that investors expected today's data release to be the near-term catalyst.</li><li>She rates the stock a Buy with a $25 (39% upside) price target.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3275836\" data-linked=\"Ra Pharma selloff a buying opportunity - Jefferies; shares down 20%\" data-tweet=\"$RARX - Ra Pharma selloff a buying opportunity - Jefferies; shares down 20% https://seekingalpha.com/news/3275836-ra-pharma-selloff-buying-opportunity-jefferies-shares-down-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3275836-ra-pharma-selloff-buying-opportunity-jefferies-shares-down-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275835\" data-ts=\"1498589608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLL\" target=\"_blank\">WLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275835-whiting-petroleumplus-2-following-investor-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whiting Petroleum +2% following investor update</a></h4><ul>     <li>Whiting Petroleum (<a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='green'>+1.9%</font>) is higher after providing an <a href=\"http://www.whiting.com/investor-relations/presentations-and-media-events/\" target=\"_blank\">investor presentation</a> alongside the J.P. Morgan energy conference, in which it says it is strongly positioned for multi-year growth.</li><li>WLL sees Q2 production of 10.2M-10.8M boe, FY 2017 45.2M-46.2M boe.</li><li>Highlights: premier core position in the Bakken and Niobrara, strong  liquidity position and strong balance sheet with no maturities until  2019, strong 2017 crude hedge position (53% hedged in 2017).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275835\" data-linked=\"Whiting Petroleum +2% following investor update\" data-tweet=\"$WLL - Whiting Petroleum +2% following investor update https://seekingalpha.com/news/3275835-whiting-petroleumplus-2-following-investor-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3275835-whiting-petroleumplus-2-following-investor-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275828\" data-ts=\"1498588121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DMTX\" target=\"_blank\">DMTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275828-dimension-therapeutics-sharpens-focus-on-key-programs-25-headcount-cut-year-end-shares-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dimension Therapeutics sharpens focus on key programs, 25% headcount cut by year-end; shares ahead 7%</a></h4><ul><li>Thinly traded nano cap Dimension Therapeutics (<a href='https://seekingalpha.com/symbol/DMTX' title='Dimension Therapeutics'>DMTX</a> <font color='green'>+7.1%</font>) shrugs off the bears on modestly higher volume. Earlier today, the company <a href=\"https://seekingalpha.com/pr/16872642-dimension-therapeutics-completes-strategic-review-updates-corporate-priorities\" target=\"_blank\">announced</a> that it completed a strategic review of its business and intends to focus its resources on three core programs:</li><li><strong>DTX301 </strong>for OTC deficiency. Initial Phase 1/2 data should be available in Q4.</li><li><strong>DTX401 </strong>for GSDIa. IND filing on tap for early 2018. Initial study data expected in mid-2018.</li><li><strong>DTX201 </strong>for hemophilia A (with Bayer). Initial trial data expected in 2018.</li><li>Part of its sharpened focus involves streamlining costs, including the termination of 25% of the workforce. The company says its current quick assets plus reimbursements/milestones from Bayer should be sufficient to fund operations through 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275828\" data-linked=\"Dimension Therapeutics sharpens focus on key programs, 25% headcount cut by year-end; shares ahead 7%\" data-tweet=\"$DMTX - Dimension Therapeutics sharpens focus on key programs, 25% headcount cut by year-end; shares ahead 7% https://seekingalpha.com/news/3275828-dimension-therapeutics-sharpens-focus-on-key-programs-25-headcount-cut-year-end-shares-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3275828-dimension-therapeutics-sharpens-focus-on-key-programs-25-headcount-cut-year-end-shares-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275830\" data-ts=\"1498587702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275830-nbc-to-offer-direct-streaming-of-premier-league-games\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NBC to offer direct streaming of Premier League games</a></h4><ul>   <li>NBC Sports (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-1%</font>) is making a major soccer-broadcast move, offering <a href=\"https://www.recode.net/2017/6/27/15880628/nbc-premier-league-streaming-soccer-subscription-tv\" target=\"_blank\">streaming access to a big chunk of games</a> without a cable subscription.</li>    <li>The division will offer an over-the-top subscription to Premier League games starting with August's new season, with 130 live games (and at least three per club) available for a $50 \"Premier League Pass.\"</li>    <li>A few other games will still appear on NBC's broadcast network and still more on NBCSN and CNBC. But the new offering doesn't call for a TV subscription at all -- and it takes what was previously a \"TV Everywhere\" feature and turns it into a potential new revenue stream for NBCUniversal.</li>    <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='red'>-1.6%</font>) earlier announced it would <a href=\"https://seekingalpha.com/news/3275800-facebook-partners-fox-live-stream-soccer-matches\" target=\"_blank\">stream a dozen-plus matches</a> from the Champions League along with Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-1.5%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-1.3%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275830\" data-linked=\"NBC to offer direct streaming of Premier League games\" data-tweet=\"$FOX $FOX $FOXA - NBC to offer direct streaming of Premier League games https://seekingalpha.com/news/3275830-nbc-to-offer-direct-streaming-of-premier-league-games?source=tweet\" data-url=\"https://seekingalpha.com/news/3275830-nbc-to-offer-direct-streaming-of-premier-league-games\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275827\" data-ts=\"1498587396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275827-marcato-capital-turns-up-heat-on-deckers-outdoor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marcato Capital turns up the heat on Deckers Outdoor</a></h4><ul> <li>Marcato Capital Management is threatening a proxy fight if Deckers Outdoor (<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+0.5%</font>) doesn't consider strategic alternatives.</li> <li>The strong push from Marcato follows its successful campaign with Buffalo Wild Wings, which ended with three board seats for the firm and a CEO resignation.</li> <li>Source: CNBC</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275827\" data-linked=\"Marcato Capital turns up the heat on Deckers Outdoor\" data-tweet=\"$DECK - Marcato Capital turns up the heat on Deckers Outdoor https://seekingalpha.com/news/3275827-marcato-capital-turns-up-heat-on-deckers-outdoor?source=tweet\" data-url=\"https://seekingalpha.com/news/3275827-marcato-capital-turns-up-heat-on-deckers-outdoor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275823\" data-ts=\"1498586716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275823-seven-week-high-for-e-l-f-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seven-week high for e.l.f. Beauty</a></h4><ul> <li>Shares of e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>) break back over $28 for the first time since May 10 with a <font color='green'>7.05% move higher</font> on strong volume.</li> <li>The rally in ELF coincides with more analysts saying that the beauty sector will hold up to the Amazon threat.</li> <li>The e.l.f. Beauty IPO priced at $17. The post-IPO high of $32.54 was struck last November.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275823\" data-linked=\"Seven-week high for e.l.f. Beauty\" data-tweet=\"$ELF - Seven-week high for e.l.f. Beauty https://seekingalpha.com/news/3275823-seven-week-high-for-e-l-f-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3275823-seven-week-high-for-e-l-f-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275822\" data-ts=\"1498586597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XENE\" target=\"_blank\">XENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275822-tevas-candidate-for-topical-treatment-of-phn-flunks-mid-stage-study-licensor-xenon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva&#39;s candidate for topical treatment of PHN flunks mid-stage study; licensor Xenon Pharmaceuticals down 22%</a></h4><ul><li>Thinly traded nano cap Xenon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='red'>-22.4%</font>) slumps on a 13x surge in volume after Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-1.5%</font>) <a href=\"https://seekingalpha.com/pr/16872788-teva-xenon-announce-phase-ii-study-topical-tvminus-45070-patients-post-herpetic-neuralgia-phn\" target=\"_blank\">announced </a>that its candidate for the topical treatment of postherpetic neuralgia &#40;PHN&#41;, TV-45070, failed to beat placebo in Phase 2 clinical trial.</li><li>Teva licensed the candidate, a small molecule inhibitor of sodium channels expressed in the pain-sensing peripheral nervous system, in December 2012.</li><li>The companies intend to completely analyze the data to determine the next steps.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275822\" data-linked=\"Teva&#39;s candidate for topical treatment of PHN flunks mid-stage study; licensor Xenon Pharmaceuticals down 22%\" data-tweet=\"$XENE $XENE $TEVA - Teva&#39;s candidate for topical treatment of PHN flunks mid-stage study; licensor Xenon Pharmaceuticals down 22% https://seekingalpha.com/news/3275822-tevas-candidate-for-topical-treatment-of-phn-flunks-mid-stage-study-licensor-xenon?source=tweet\" data-url=\"https://seekingalpha.com/news/3275822-tevas-candidate-for-topical-treatment-of-phn-flunks-mid-stage-study-licensor-xenon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275820\" data-ts=\"1498586403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275820-consumer-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275820\" data-linked=\"Consumer - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$ELF $IRBT $VOXX - Consumer - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3275820-consumer-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3275820-consumer-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275744\" data-ts=\"1498584958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275744-healthcare-top-5-gainers-losers-of-1-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 1:30 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics Inc'>ADMA</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/OSUR' title='OraSure Technologies, Inc.'>OSUR</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LENS' title='Presbia'>LENS</a> <font color='red'>-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275744\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 1:30 pm\" data-tweet=\"$MBRX $CFRX $ADMA - Healthcare - Top 5 Gainers / Losers as of 1:30 pm https://seekingalpha.com/news/3275744-healthcare-top-5-gainers-losers-of-1-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3275744-healthcare-top-5-gainers-losers-of-1-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275811\" data-ts=\"1498583666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275811-financials-top-5-gainers-losers-of-1-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:15 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NSA' title='National Storage Affiliates Trust'>NSA</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FSAM' title='Fifth Street Asset Management Inc.A'>OTCPK:FSAM</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275811\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:15 PM\" data-tweet=\"$NSA $FSAM $WHF - Financials - Top 5 Gainers / Losers as of 1:15 PM https://seekingalpha.com/news/3275811-financials-top-5-gainers-losers-of-1-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3275811-financials-top-5-gainers-losers-of-1-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275810\" data-ts=\"1498583352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CJREF\" target=\"_blank\">CJREF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275810-corus-entertainmentplus-2_6-on-strong-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corus Entertainment +2.6% on strong revenue growth</a></h4><ul>   <li>Corus Entertainment (<a href='https://seekingalpha.com/symbol/CJREF' title='Corus Entertainment, Inc.B'>OTCPK:CJREF</a>) is <font color='green'>up 2.6%</font> in U.S. trading after its <a href=\"https://seekingalpha.com/news/3275649-corus-entertainment-reports-q3-results\" target=\"_blank\">Q3 results</a> beat analysts' revenue expectations amid a return to growth as it integrated the operations of acquired Shaw Media.</li>    <li>Revenues grew 28% Y/Y; on a pro forma basis, they rose 3%. Year-to-date revenues are up 65% Y/Y. Television powered revenue gains, with ad gains up 33% while subscriber revenues increased 26% and merchandise/distribution and other sales rose 47%.</li>    <li>Meanwhile, profits grew 35% (14% on a pro forma basis). EPS of C$0.35 missed consensus of C$0.37.</li>    <li>Revenue by segment: Television, C$422.3M (up 31.5%); Radio, C$39.3M (down 0.9%).</li>    <li>Profit by segment: Television, C$171.3M (up 33.9%); Radio, C$11.6M (up 20%); Corporate, -C$7.1M.</li>    <li><a href=\"https://seekingalpha.com/pr/16872447-corus-entertainment-announces-fiscal-2017-third-quarter-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3275810\" data-linked=\"Corus Entertainment +2.6% on strong revenue growth\" data-tweet=\"$CJREF - Corus Entertainment +2.6% on strong revenue growth https://seekingalpha.com/news/3275810-corus-entertainmentplus-2_6-on-strong-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3275810-corus-entertainmentplus-2_6-on-strong-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275806\" data-ts=\"1498582123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/K\" target=\"_blank\">K</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275806-bernstein-warns-on-kellogg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bernstein warns on Kellogg</a></h4><ul> <li>Bernstein is out with a cautionary note on Kellogg (<a href='https://seekingalpha.com/symbol/K' title='Kellogg Company'>K</a> <font color='red'>-1.7%</font>) as it backs its Underperform rating and $62 price target.</li> <li>Analyst Alexia Howard says investors are starting to question why Kellogg is extending payment terms to some of its customers and wondering if the company has lost some leverage with vendors.</li> <li>Shares of Kellogg are down 4% over the last six weeks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275806\" data-linked=\"Bernstein warns on Kellogg\" data-tweet=\"$K - Bernstein warns on Kellogg https://seekingalpha.com/news/3275806-bernstein-warns-on-kellogg?source=tweet\" data-url=\"https://seekingalpha.com/news/3275806-bernstein-warns-on-kellogg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275805\" data-ts=\"1498581905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275805-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/SHLO' title='Shiloh Industries, Inc.'>SHLO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SYX' title='Systemax Inc.'>SYX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LENS' title='Presbia'>LENS</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275805\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CBI $MBRX $APDN - Midday Gainers / Losers https://seekingalpha.com/news/3275805-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3275805-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275803\" data-ts=\"1498581852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275803-interest-rate-surge-sends-financial-sector-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interest rate surge sends financial sector up more than 1%</a></h4><ul><li>The major averages are in the red, but the <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> is&nbsp;<font color='green'>up 1.1%</font>&nbsp;after some <a href=\"https://seekingalpha.com/news/3275801-bond-yields-leap-draghi-turns-somewhat-hawkish\" target=\"_blank\">hawkish talk from</a> the ECB's Mario Draghi sent bond yields surging both in the EU and in the U.S.</li><li>The 10-year Treasury yield is up 6.3 basis points to 2.203%.</li><li>The SPDR KBW Regional Banking ETF (<a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> <font color='green'>+1.4%</font>), the SPDR KBW Bank ETF (<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> <font color='green'>+1.4%</font>)</li><li>Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='green'>+2.7%</font>), JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='green'>+1.7%</font>), Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color='green'>+1.6%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='green'>+2%</font>), PNC Financial (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='green'>+1.7%</font>), Schwab (<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a> <font color='green'>+3.1%</font>), E*Trade (<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a> <font color='green'>+2%</font>), MetLife (<a href='https://seekingalpha.com/symbol/MET' title='MetLife, Inc.'>MET</a> <font color='green'>+1.8%</font>), Prudential (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='green'>+1.7%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a>, <a href='https://seekingalpha.com/symbol/FXO' title='First Trust Financials AlphaDEX ETF'>FXO</a>, <a href='https://seekingalpha.com/symbol/SEF' title='ProShares Short Financials ETF'>SEF</a>, <a href='https://seekingalpha.com/symbol/RYF' title='Invesco S&P Equal Weight Financial ETF'>RYF</a>, <a href='https://seekingalpha.com/symbol/FINU' title='ProShares UltraPro Financials ETF'>FINU</a>, <a href='https://seekingalpha.com/symbol/XLFS' title='Financial Services Select Sector SPDR ETF'>XLFS</a>, <a href='https://seekingalpha.com/symbol/FINZ' title='ProShares UltraPro Short Financials ETF'>FINZ</a>, <a href='https://seekingalpha.com/symbol/RWW' title='Oppenheimer Financials Sector Revenue ETF'>RWW</a>, <a href='https://seekingalpha.com/symbol/FAZZ' title='Direxion Daily Financial Bear 1x Shares ETF'>FAZZ</a>, <a href='https://seekingalpha.com/symbol/JHMF' title='John Hancock Multifactor Financials ETF'>JHMF</a>, <a href='https://seekingalpha.com/symbol/FNCF' title='iShares Edge MSCI Multifactor Financials ETF'>FNCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275803\" data-linked=\"Interest rate surge sends financial sector up more than 1%\" data-tweet=\"$BAC $XLF $KRE - Interest rate surge sends financial sector up more than 1% https://seekingalpha.com/news/3275803-interest-rate-surge-sends-financial-sector-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3275803-interest-rate-surge-sends-financial-sector-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275801\" data-ts=\"1498581332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275801-bond-yields-leap-draghi-turns-somewhat-hawkish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bond yields leap as Draghi turns (somewhat) hawkish</a></h4><ul><li>\"The threat of deflation is gone and reflationary forces are at play,\" <a href=\"https://seekingalpha.com/news/3275645-euro-leaps-draghi-speaks\" target=\"_blank\">said Mario Draghi earlier today</a>, though quickly adding that this doesn't mean ECB policy tightening is imminent.</li><li>His remarks have sent the euro surging to its highest level vs. the dollar in nearly a year. Also surging are bond yields, with the German 10-year Bund up 12.6 basis points to 0.374%. The Italian 10-year yield is up a similar amount.</li><li>It's spilled over to the U.S., where the 10-year Treasury yield is higher by 6.5 basis points to 2.204%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-1.1%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+2.2%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Government Bond Index ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/TLO' title='SPDR Barclays Long Term Treasury ETF'>TLO</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/GGOV' title='ProShares German Sovereign/Sub-Sovereign ETF'>GGOV</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275801\" data-linked=\"Bond yields leap as Draghi turns (somewhat) hawkish\" data-tweet=\"$TLT $TBT $TMV - Bond yields leap as Draghi turns (somewhat) hawkish https://seekingalpha.com/news/3275801-bond-yields-leap-draghi-turns-somewhat-hawkish?source=tweet\" data-url=\"https://seekingalpha.com/news/3275801-bond-yields-leap-draghi-turns-somewhat-hawkish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275799\" data-ts=\"1498580627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCH\" target=\"_blank\">PCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275799-timber-lower-raymond-james-heads-to-sidelines-on-potlatch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Timber lower as Raymond James heads to sidelines on Potlatch</a></h4><ul><li>Potlatch (NASDAQ:<a href='https://seekingalpha.com/symbol/PCH' title='PotlatchDeltic Corp.'>PCH</a>) is&nbsp;<font color='green'>higher by 15%</font>&nbsp;this year and&nbsp;<font color='green'>nearly 50%</font>&nbsp;Y/Y, but&nbsp;<font color='red'>down 4.35%</font>&nbsp;today after Raymond James <a href=\"https://www.streetinsider.com/Downgrades/Raymond+James+Downgrades+Potlatch+%28PCh%29+to+Market+Perform/13047166.html\" target=\"_blank\">downgrades to</a> Market Perform from Outperform. That leaves the company with exactly zero buy ratings among the eight sell-siders who cover it.</li><li>Perhaps in concert, Weyerhaeuser (NYSE:<a href='https://seekingalpha.com/symbol/WY' title='Weyerhaeuser Co.'>WY</a>) is&nbsp;<font color='red'>down 1.85%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275799\" data-linked=\"Timber lower as Raymond James heads to sidelines on Potlatch\" data-tweet=\"$PCH $PCH $WY - Timber lower as Raymond James heads to sidelines on Potlatch https://seekingalpha.com/news/3275799-timber-lower-raymond-james-heads-to-sidelines-on-potlatch?source=tweet\" data-url=\"https://seekingalpha.com/news/3275799-timber-lower-raymond-james-heads-to-sidelines-on-potlatch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275793\" data-ts=\"1498579892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLKB\" target=\"_blank\">BLKB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275793-blackbaud-and-national-storage-higher-after-battlefield-promotions-from-s-and-p\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blackbaud and National Storage both higher after battlefield promotions from S&amp;P</a></h4><ul><li>Blackbaud (<a href='https://seekingalpha.com/symbol/BLKB' title='Blackbaud, Inc.'>BLKB</a> <font color='green'>+2.4%</font>) will replace the soon-to-be acquired CST Brands in the S&amp;P MidCap 400, effective prior to the open on June 29.</li><li>Taking Blackbaud's place in the S&amp;P SmallCap 600 will be National Storage Affiliates (<a href='https://seekingalpha.com/symbol/NSA' title='National Storage Affiliates Trust'>NSA</a> <font color='green'>+6.1%</font>).</li><li>Source: <a href=\"https://seekingalpha.com/pr/16872242-b-blackbaud-b-set-join-s-and-p-midcap-400-national-storage-affiliates-trust-join-s-and-p\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275793\" data-linked=\"Blackbaud and National Storage both higher after battlefield promotions from S&amp;P\" data-tweet=\"$BLKB $BLKB $NSA - Blackbaud and National Storage both higher after battlefield promotions from S&amp;P https://seekingalpha.com/news/3275793-blackbaud-and-national-storage-higher-after-battlefield-promotions-from-s-and-p?source=tweet\" data-url=\"https://seekingalpha.com/news/3275793-blackbaud-and-national-storage-higher-after-battlefield-promotions-from-s-and-p\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275788\" data-ts=\"1498578150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMS\" target=\"_blank\">BMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275788-bemis-gets-second-upgrade-in-three-days-barclays-boosts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bemis gets second upgrade in three days as Barclays boosts</a></h4><ul>     <li>Bemis (<a href='https://seekingalpha.com/symbol/BMS' title='Bemis Company, Inc.'>BMS</a> <font color='green'>+1.7%</font>) is <a href=\"http://thefly.com/thestreet/realmoney/index.php/BMSid2571673/BMS-Bemis-upgraded-to-Overweight-from-Equal-Weight-at-Barclays\" target=\"_blank\">upgraded</a> to Overweight from Equal Weight with a $54 price target, raised from $43, at Barclays based on improved earnings potential and free cash flow power during the next 12-18 months.</li><li>Barclays says It's easy for investors to be negative on BMS shares following the  significant cut to FY 2017 guidance, weaker CPG  volumes and a stalled transformation, but these appear to be  fully priced in; what is less well understood is the upside  as the company shifts from transformation to a self-funded turnaround.</li><li>The firm thinks Q2 likely represents a trough for earnings performance as resin  headwinds abate, H2 volumes accelerate and turnaround initiatives  begin to materialize.</li><li>It's the second upgrade in the past three sessions, as BMO Capital <a href=\"http://thefly.com/thestreet/realmoney/index.php/BMSid2570741/BMS-Bemis-upgraded-on-restructuring-promises-new-business-wins-at-BMO-Capital\" target=\"_blank\">upped shares last Friday</a> after meeting with management, and the firm now expects restructuring announcements within the next 1-2 weeks.</li><li>BMO expects BMS&rsquo;s Q2 to be hurt by $5M-$8M of incremental costs from the SAP  implementation but the company should benefit from volume  gains and cost cutting moving toward 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275788\" data-linked=\"Bemis gets second upgrade in three days as Barclays boosts\" data-tweet=\"$BMS $AMCR - Bemis gets second upgrade in three days as Barclays boosts https://seekingalpha.com/news/3275788-bemis-gets-second-upgrade-in-three-days-barclays-boosts?source=tweet\" data-url=\"https://seekingalpha.com/news/3275788-bemis-gets-second-upgrade-in-three-days-barclays-boosts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275783\" data-ts=\"1498577270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARX\" target=\"_blank\">RARX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275783-ra-pharma-initial-report-of-mid-stage-results-for-lead-candidate-ra101495-in-pnh-based-on-two\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ra Pharma initial report of mid-stage results for lead candidate RA101495 in PNH based on two patients, another relapsed; shares down 23%</a></h4><ul><li>Thinly traded micro cap Ra Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <font color='red'>-22.8%</font>) is under pressure on a 5x surge in volume after it <a href=\"https://seekingalpha.com/pr/16872481-ra-pharmaceuticals-announces-initial-data-phase-2-clinical-trial-ra101495-pnh\" target=\"_blank\">reported </a>initial data from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03078582?term=ra+pharmaceuticals&amp;intr=ra101495&amp;rank=2\" target=\"_blank\">Phase 2 study</a> assessing lead candidate RA101495 for the treatment of rare inherited blood disorder called paroxysmal nocturnal hemoglobinuria &#40;PNH&#41;.</li><li>The study has three participants so far, all naive to treatment with Alexion Pharmaceuticals' Soliris (eculizumab). The initial dataset only includes the two patients who completed seven weeks' follow-up. The enrollment target is 20. The estimated study completion date is February 2018.</li><li>No safety or tolerability signals were observed and no injection site reactions. Inhibition of hemolytic activity was almost complete. Rapid declines in an enzyme called lactate dehydrogenase &#40;LDH&#41; were also observed.</li><li>One patient (out of three) reported a recurrence of PNH symptoms associated with hemoglobinuria (hemoglobin in urine) and elevated LDH.</li><li>The value proposition of RA101495, a complement component 5 inhibitor, is self-administered subcutaneous injection. Soliris is a monoclonal antibody administered via IV infusion over a period of 35 minutes in adult patients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275783\" data-linked=\"Ra Pharma initial report of mid-stage results for lead candidate RA101495 in PNH based on two patients, another relapsed; shares down 23%\" data-tweet=\"$RARX - Ra Pharma initial report of mid-stage results for lead candidate RA101495 in PNH based on two patients, another relapsed; shares down 23% https://seekingalpha.com/news/3275783-ra-pharma-initial-report-of-mid-stage-results-for-lead-candidate-ra101495-in-pnh-based-on-two?source=tweet\" data-url=\"https://seekingalpha.com/news/3275783-ra-pharma-initial-report-of-mid-stage-results-for-lead-candidate-ra101495-in-pnh-based-on-two\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275780\" data-ts=\"1498576436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275780-chesapeake-ceo-sees-debt-cuts-higher-production-aiding-revival\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake CEO sees debt cuts, higher production aiding revival</a></h4><ul>     <li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='green'>+1.9%</font>) moves higher following the disclosure that a director <a href=\"https://www.streetinsider.com/SEC+Filings/Form+4+CHESAPEAKE+ENERGY+CORP+For%3A+Jun+23+Filed+by%3A+MARTIN+R+BRAD/13047092.html\" target=\"_blank\">purchased</a> 20.4K shares at $4.55/share.</li>     <li>The move extends yesterday's 2% gain after CHK said at a J.P. Morgan energy sector conference that it <a href=\"https://www.thestreet.com/story/14196643/1/cheaspeake-s-woes-bottomed-out-in-q1-says-ceo-who-sees-debt-cuts-higher-production-aiding-comeback.html\" target=\"_blank\">expects to sell $2B-$4B of debt</a> from its balance sheet by 2018.</li>     <li>President and CEO Robert Lawler declined to provide earnings guidance, instead assuring conference attendees that \"we're focused on driving down our debt further. And we remain very, very flexible with tremendous optionality on oil and gas across the portfolio.\"</li>     <li>Lawler also said the company's Eagle Ford wells would be more productive and lucrative in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275780\" data-linked=\"Chesapeake CEO sees debt cuts, higher production aiding revival\" data-tweet=\"$CHK - Chesapeake CEO sees debt cuts, higher production aiding revival https://seekingalpha.com/news/3275780-chesapeake-ceo-sees-debt-cuts-higher-production-aiding-revival?source=tweet\" data-url=\"https://seekingalpha.com/news/3275780-chesapeake-ceo-sees-debt-cuts-higher-production-aiding-revival\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275779\" data-ts=\"1498576298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275779-ascena-retail-rallies-after-fbr-capital-weighs-in-favorably\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascena Retail rallies after FBR Capital weighs in favorably</a></h4><ul> <li>Shares of Ascena Retail Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a>) are <font color='green'>up 12.82%</font> and still climbing after FBR Capital issues a positive note after meeting with management.</li> <li>FBR analyst Susan Anderson is more confident that Ascena can \"navigate the continued structural shifts\" in motion.</li> <li>The firm keeps a Market Perform rating on ASNA&nbsp;in place as it waits for margins to improve and the balance sheet to de-risk.</li> <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275779\" data-linked=\"Ascena Retail rallies after FBR Capital weighs in favorably\" data-tweet=\"$ASNA - Ascena Retail rallies after FBR Capital weighs in favorably https://seekingalpha.com/news/3275779-ascena-retail-rallies-after-fbr-capital-weighs-in-favorably?source=tweet\" data-url=\"https://seekingalpha.com/news/3275779-ascena-retail-rallies-after-fbr-capital-weighs-in-favorably\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275778\" data-ts=\"1498576197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHF\" target=\"_blank\">WHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275778-whitehorse-finance-down-6_7-after-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WhiteHorse Finance down 6.7% after share sale</a></h4><ul><li>The offering was downsized to 2.2M shares (from 2.5M), and priced at $13.97 each; net proceeds to be $30.2M.</li><li>The external manager has agreed to pay some of the underwriting costs in order that net proceeds end up being above NAV per share ($13.80 as of March 31).</li><li>The shareholders &nbsp;are putting up the 330K shares for the underwriter greenshoe option.</li><li><a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a>&nbsp;<font color='red'>-6.7%</font>&nbsp;to $13.41.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3275662-whitehorse-finance-5-percent-capital-raise\" target=\"_blank\">Whitehorse Finance down more than 5% on capital raise</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3275778\" data-linked=\"WhiteHorse Finance down 6.7% after share sale\" data-tweet=\"$WHF - WhiteHorse Finance down 6.7% after share sale https://seekingalpha.com/news/3275778-whitehorse-finance-down-6_7-after-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3275778-whitehorse-finance-down-6_7-after-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275774\" data-ts=\"1498575429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMA\" target=\"_blank\">ADMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275774-adma-bio-set-for-growth-after-acquisition-of-biotest-assets-relaunch-of-bivigam-imminent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADMA Bio set for growth after acquisition of Biotest assets, relaunch of Bivigam imminent; shares ahead 14%</a></h4><ul><li>Thinly traded ADMA Biologics (<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics Inc'>ADMA</a> <font color='green'>+14.4%</font>) perks up on double normal volume, albeit on only 60K shares, in response to its progress in getting an acquired biologics manufacturing facility back on track after upgrades and renovations and relaunching key products.</li><li>In a<a href=\"https://seekingalpha.com/pr/16872536-adma-biologics-provides-corporate-timeline-activities-update-stockholders\" target=\"_blank\"> letter to shareholders</a>, founder and CEO Adam Grossman says the Boca Raton, FL site should be \"inspection ready\" in about six months when it completes the work required to resolve GMP-related issues cited in a July 2016 FDA Warning Letter.</li><li>The facility will produce BIVIGAM and Nabi-HB (Hepatitis B Immune Globulin, Human). BIVIGAM production was shut down by previous owner Biotest Pharmaceuticals in order to upgrade and renovate the site. BIVIGAM accounted for $50M of the $76.5M in 2016 sales from the Boca location.</li><li>Mr. Grossman adds that his team expects to refile the Biologics License Application &#40;BLA&#41; for lead candidate RI-002 by mid-2018. <a href=\"http://www.admabiologics.com/therapies\" target=\"_blank\">RI-002 </a>is derived from human plasma blended from normal donors and donors known to have high titers of RSV antibodies. The final product has naturally occurring antibodies against strep,flu, CMV, measles and tetanus. It will be used to prevent infections in immune-compromised patients.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3236624-adma-biologics-acquire-certain-assets-biotest-pharmaceuticals\" target=\"_blank\">ADMA Biologics to acquire certain assets from Biotest Pharmaceuticals</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3275774\" data-linked=\"ADMA Bio set for growth after acquisition of Biotest assets, relaunch of Bivigam imminent; shares ahead 14%\" data-tweet=\"$ADMA - ADMA Bio set for growth after acquisition of Biotest assets, relaunch of Bivigam imminent; shares ahead 14% https://seekingalpha.com/news/3275774-adma-bio-set-for-growth-after-acquisition-of-biotest-assets-relaunch-of-bivigam-imminent?source=tweet\" data-url=\"https://seekingalpha.com/news/3275774-adma-bio-set-for-growth-after-acquisition-of-biotest-assets-relaunch-of-bivigam-imminent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275775\" data-ts=\"1498575403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275775-cheniere-energy-preparing-for-next-round-of-export-projects-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheniere Energy preparing for next round of export projects, CEO says</a></h4><ul>     <li>Cheniere Energy (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc'>LNG</a> <font color='green'>+1.8%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2017-06-26/cheniere-gets-ready-for-next-round-in-global-gas-export-market\" target=\"_blank\">looking at new ways to finance more terminals</a> that chill gas to a liquid and ship it across the globe, including skipping banks altogether and seeking out other capital sources, CEO Jack Fusco tells Bloomberg.</li>     <li>LNG has leased additional acres at its flagship Sabine Pass terminal in Louisiana and has the option to purchase more land at a Corpus Christi, Tex., site, where another export project is under construction.</li>     <li>&ldquo;Our goal is to leverage the existing infrastructure to build whatever  the next round requires,&rdquo; Fusco says, adding that the company \"can do a better job financing and getting our financing costs down in the capital markets.\"</li>     <li>Fusco says LNG is open to building plants smaller than the  ones operating at Sabine Pass, which can each produce 4.5M tons /year of liquefied natural gas.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275775\" data-linked=\"Cheniere Energy preparing for next round of export projects, CEO says\" data-tweet=\"$LNG - Cheniere Energy preparing for next round of export projects, CEO says https://seekingalpha.com/news/3275775-cheniere-energy-preparing-for-next-round-of-export-projects-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3275775-cheniere-energy-preparing-for-next-round-of-export-projects-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275773\" data-ts=\"1498575308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275773-cb-and-i-gets-lift-from-ruling-reversal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CB&amp;I gets lift from ruling reversal</a></h4><ul><li>Chicago Bridge (<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='green'>+15%</font>) soars in early trade after Bloomberg <a href=\"https://www.streetinsider.com/Corporate+News/Westinghouse+Case+vs+Chicago+Bridge+%26+Iron+%28CBI%29+Remanded+to+Court+of+Chancery%2C+Ruling+Reversed+-+Bloomberg/13048472.html\" target=\"_blank\">reported</a> that the judgement in its Dec. 5 case with Westinghouse was reversed.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3195672-cb-cut-neutral-buy-citi-westinghouse-disappointment\" target=\"_blank\">CB&amp;I cut to Neutral from Buy at Citi on Westinghouse disappointment</a> (Jul. 25 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3275773\" data-linked=\"CB&amp;I gets lift from ruling reversal\" data-tweet=\"$CBI - CB&amp;I gets lift from ruling reversal https://seekingalpha.com/news/3275773-cb-and-i-gets-lift-from-ruling-reversal?source=tweet\" data-url=\"https://seekingalpha.com/news/3275773-cb-and-i-gets-lift-from-ruling-reversal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>97&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275772\" data-ts=\"1498575190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNRO\" target=\"_blank\">MNRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275772-stephens-warns-on-amazon-impact-for-monro-muffler-brake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens warns on Amazon impact for Monro Muffler Brake</a></h4><ul> <li>Monro Muffler Brake (NASDAQ:<a href='https://seekingalpha.com/symbol/MNRO' title='Monro, Inc.'>MNRO</a>) is&nbsp;<font color='red'>down 2.48%</font>&nbsp;after Stephens warns that Amazon is increasing its focus in the tire category.</li> <li>Tires accounted for 49% of Monro Muffler's revenue last year, notes the firm.</li> <li>For now, Stephens is sticking with an Overweight rating and $69 price target on Monro, but is going to run the numbers on a potential AMZN impact in the near future.</li> <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275772\" data-linked=\"Stephens warns on Amazon impact for Monro Muffler Brake\" data-tweet=\"$MNRO - Stephens warns on Amazon impact for Monro Muffler Brake https://seekingalpha.com/news/3275772-stephens-warns-on-amazon-impact-for-monro-muffler-brake?source=tweet\" data-url=\"https://seekingalpha.com/news/3275772-stephens-warns-on-amazon-impact-for-monro-muffler-brake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275763\" data-ts=\"1498573951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275763-kroger-higher-ceo-talks-post-amazon-wfm-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kroger higher as CEO talks post-Amazon/WFM strategy</a></h4><ul> <li>Kroger (<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='green'>+2.2%</font>) CEO Rodney McMullen visited with <a href=\"http://www.cnbc.com/latest-video/\" target=\"_blank\">CNBC</a> this morning to discuss his company's strategy in the post-Amazon/Whole Foods grocery world.</li> <li>Not a surprise, but McMullen didn't discuss any specific M&amp;A plans, although he did say the company is not constrained by its balance sheet.</li> <li>On the threat of wider distriubtion of Whole Foods brands, the exec was quick to point out that Kroger has been steadily growing market share for its private label brands and doesn't expect that trend to change.</li> <li>It's hard to say for sure that McMullen talked up Kroger's share price, but there's no denying the stock made gains as the interview progressed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275763\" data-linked=\"Kroger higher as CEO talks post-Amazon/WFM strategy\" data-tweet=\"$KR - Kroger higher as CEO talks post-Amazon/WFM strategy https://seekingalpha.com/news/3275763-kroger-higher-ceo-talks-post-amazon-wfm-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3275763-kroger-higher-ceo-talks-post-amazon-wfm-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275756\" data-ts=\"1498573144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275756-report-white-house-considering-additional-penalties-for-steel-dumping\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: White House considering additional penalties for steel dumping</a></h4><ul>     <li>The afterglow of Chinese Pres. Xi's April meeting with Pres. Trump has faded, and sources say the administration now <a href=\"https://www.axios.com/trumps-china-honeymoon-is-over-2449029013.html\" target=\"_blank\">will be tougher on China</a>, <em>Axios</em> reports.</li>     <li>Top White House aide Steve Bannon and his allies in key trade and policy positions are agitating for a high-profile economic fight with China, part of which likely would manifest itself in penalties that would deter or punish foreign dumping of steel (<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a> <font color='green'>+1.5%</font>) into the U.S. market, according to the report.</li><li>Commerce Secretary Ross reportedly has shared the findings of his  investigation into steel dumping, and a meeting was held yesterday at the White House about next steps.</li><li>Steel names are higher in early trading: <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+1%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+5.8%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+3.2%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+1%</font>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a> <font color='green'>+3.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275756\" data-linked=\"Report: White House considering additional penalties for steel dumping\" data-tweet=\"$X $SLX $X - Report: White House considering additional penalties for steel dumping https://seekingalpha.com/news/3275756-report-white-house-considering-additional-penalties-for-steel-dumping?source=tweet\" data-url=\"https://seekingalpha.com/news/3275756-report-white-house-considering-additional-penalties-for-steel-dumping\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275748\" data-ts=\"1498572013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSX\" target=\"_blank\">BSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275748-boston-scientific-hosts-investor-day-today-goal-of-6minus-8-organic-annual-revenue-growth-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Scientific hosts Investor Day today; goal of 6-8% organic annual revenue growth and double-digit annual non-GAAP EPS growth next three years; shares up 1%</a></h4><ul><li>Boston Scientific (<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a> <font color='green'>+1%</font>) hosts its <a href=\"https://seekingalpha.com/pr/16872551-boston-scientific-outlines-strategy-sustained-growth-2017-investor-day\" target=\"_blank\">Investor Day</a> today in New York. Management will review its plans to deliver 6 - 8% top-line growth and double-digit earnings growth through 2020. Highlights:</li><li>Presentation of new products and pipeline technologies to drive category leadership.</li><li>Cardiovascular: review of market-leading SYNERGY DES (drug-eluting stent).</li><li>Structural Heart: review of market opportunities and clinical strategies for WATCHMAN LAAC device, TAVR valve platforms, LOTUS Edge Valve and ACURATE neo AS Valve. LOTUS Edge commercial launch in Europe and marketing application in U.S. expected in Q4.</li><li>Peripheral Interventions: update on DES and drug-coated balloon &#40;DCB&#41; portfolio. Recently received first-ever Expedited Access Pathway designation from the FDA for drug-eluting vascular stent system for the treatment of critical limb ischemia below the knee.</li><li>Rhythm Management: review of RESONATE family of cardiac resynchronization therapy defibrillator (CRT-D) devices. By 2019, the company expects to have an Insertable Cardiac Monitor solution with a diagnostic-only device platform for cardiac arrhythmia monitoring through a mobile patient interface.</li><li>MedSurg: investing in technologies to support potential entry into $3.5B in new endoscopy markets.</li><li>The company expects 75% of its 2020 sales to come from moderate-to-high growth markets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275748\" data-linked=\"Boston Scientific hosts Investor Day today; goal of 6-8% organic annual revenue growth and double-digit annual non-GAAP EPS growth next three years; shares up 1%\" data-tweet=\"$BSX - Boston Scientific hosts Investor Day today; goal of 6-8% organic annual revenue growth and double-digit annual non-GAAP EPS growth next three years; shares up 1% https://seekingalpha.com/news/3275748-boston-scientific-hosts-investor-day-today-goal-of-6minus-8-organic-annual-revenue-growth-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3275748-boston-scientific-hosts-investor-day-today-goal-of-6minus-8-organic-annual-revenue-growth-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275743\" data-ts=\"1498571337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275743-pier-1-imports-perks-up-after-gordon-haskett-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier 1 Imports perks up after Gordon Haskett upgrade</a></h4><ul> <li>Shares of Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a>) are <font color='green'>up 3.05%</font> after Gordon Haskett lifts the retailer to Hold from Reduce.</li> <li>The boutique firm sets a price target of $6 on Pier to rep 12% upside potential.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3275743\" data-linked=\"Pier 1 Imports perks up after Gordon Haskett upgrade\" data-tweet=\"$PIR - Pier 1 Imports perks up after Gordon Haskett upgrade https://seekingalpha.com/news/3275743-pier-1-imports-perks-up-after-gordon-haskett-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3275743-pier-1-imports-perks-up-after-gordon-haskett-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275741\" data-ts=\"1498571229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POWI\" target=\"_blank\">POWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275741-power-integrations-reportedly-wins-iphone-8-business-sharesplus-1_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Power Integrations reportedly wins iPhone 8 business; shares +1.4%</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>Rosenblatt's Jun Zhang says Power Integrations (<a href='https://seekingalpha.com/symbol/POWI' title='Power Integrations, Inc.'>POWI</a> <font color='green'>+1.4%</font>) has won the iPhone 8 fast-charging controller business.</li><li>It's a big deal, says Zhang, whose back-of-the-envelope work suggests a 25% boost to POWI's 2018 revenues and EPS.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275741\" data-linked=\"Power Integrations reportedly wins iPhone 8 business; shares +1.4%\" data-tweet=\"$POWI - Power Integrations reportedly wins iPhone 8 business; shares +1.4% https://seekingalpha.com/news/3275741-power-integrations-reportedly-wins-iphone-8-business-sharesplus-1_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3275741-power-integrations-reportedly-wins-iphone-8-business-sharesplus-1_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275739\" data-ts=\"1498571142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275739-analysts-see-positivity-in-sprint-cable-deal-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts see positivity in Sprint/cable deal talks</a></h4><ul>   <li>A <a href=\"https://seekingalpha.com/news/3275622-wsj-sprint-exploring-wireless-deal-charter-comcast\" target=\"_blank\">potential resale deal</a> between Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) and Charter (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) and Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) makes more sense than straightforward M&amp;A, says Pacific Crest.</li>    <li>Charter and Comcast are in a long-in-the-works setup to offer mobile virtual network operator service by <a href=\"https://seekingalpha.com/news/3210232-charter-ceo-wireless-service-ambition-capital-allocation\" target=\"_blank\">re-selling Verizon airwaves</a>. But that deal limits the economics and scale of what the two cablecos can offer.</li>    <li>Such a deal with Sprint would help shore up Sprint's network while putting the carrier's underutilized spectrum to work, analyst Brandon Nispel notes.</li>    <li>It's a big new option for Sprint, says Wells Fargo's Jennifer Fritzsche: \"Many think that Sprint really had its back against the wall and many thought if T-Mobile were to happen, it would essentially be a take-under.\"</li>    <li>Meanwhile, it's <a href=\"http://www.cnbc.com/2017/06/27/sprint-gains-on-deal-chatter-that-doesnt-involve-a-t-mobile-merger-analyst.html\" target=\"_blank\">unlikely that Charter and Comcast will take any equity stake in Sprint</a>, CNBC's David Faber says. People familiar with the talks tell him the focus is on getting an MVNO put together.</li>    <li>Now: <a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='green'>+4.2%</font>; <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='red'>-3%</font>; <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-1.1%</font>; <a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a> <font color='red'>-1.8%</font>; <a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color='red'>-1.1%</font>; <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='red'>-0.8%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3264407-wsj-comcast-charter-forming-wireless-partnership\" target=\"_blank\">WSJ: Comcast, Charter forming wireless partnership</a> (May. 07 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275739\" data-linked=\"Analysts see positivity in Sprint/cable deal talks\" data-tweet=\"$S $S $CHTR - Analysts see positivity in Sprint/cable deal talks https://seekingalpha.com/news/3275739-analysts-see-positivity-in-sprint-cable-deal-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3275739-analysts-see-positivity-in-sprint-cable-deal-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275737\" data-ts=\"1498570740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275737-oils-on-four-day-winning-streak\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil&#39;s on a four-day winning streak</a></h4><ul><li>Crude is&nbsp;<font color='green'>up another 1.15%</font>&nbsp;this morning to $43.88 per barrel, continuing a bounce from late last week when it touched an eight-month low of $42.</li><li>The move at this point is little more than a blip<a href=\"http://finviz.com/futures_charts.ashx?p=d1&amp;t=CL\" target=\"_blank\"> on a one-month downtrend</a> that started at $52 per barrel.</li><li>After the close, we get inventory data from the API. The EIA's inventory numbers come tomorrow morning, and stocks are seen dropping 2.25M barrels.</li><li><a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>&nbsp;<font color='green'>+0.85%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275737\" data-linked=\"Oil&#39;s on a four-day winning streak\" data-tweet=\"$USO $OIL $UWT - Oil&#39;s on a four-day winning streak https://seekingalpha.com/news/3275737-oils-on-four-day-winning-streak?source=tweet\" data-url=\"https://seekingalpha.com/news/3275737-oils-on-four-day-winning-streak\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275735\" data-ts=\"1498570446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275735-another-new-patient-enrolled-in-invivos-inspire-study-shares-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another new patient enrolled in InVivo&#39;s INSPIRE study; shares up 12%</a></h4><ul><li>InVivo Therapeutics (<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a>) jumps out the blocks in response to its <a href=\"https://seekingalpha.com/pr/16872645-invivo-therapeutics-announces-new-patient-enrollment-inspire-study-thomas-jefferson\" target=\"_blank\">announcement </a>of the enrollment of a new patient in the INSPIRE study assessing its Neuro-Spinal Scaffold in people with complete thoracic AIS A spinal cord injury. Enrollment is now 17.</li><li>Shares are up&nbsp;<font color='green'>12%</font>&nbsp;on double normal volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3257090-invivo-amend-inspire-protocol-40-new-patients-participate-shares-slump-6-percent-efficacy\" target=\"_blank\">InVivo to amend INSPIRE protocol, up to 40 new patients to participate; shares slump 6% on efficacy implications</a> (April 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3275735\" data-linked=\"Another new patient enrolled in InVivo&#39;s INSPIRE study; shares up 12%\" data-tweet=\"$NVIV - Another new patient enrolled in InVivo&#39;s INSPIRE study; shares up 12% https://seekingalpha.com/news/3275735-another-new-patient-enrolled-in-invivos-inspire-study-shares-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3275735-another-new-patient-enrolled-in-invivos-inspire-study-shares-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275731\" data-ts=\"1498569969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYN\" target=\"_blank\">SYN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275731-synthetic-bio-nabs-u-s-patent-covering-lead-product-candidate-synminus-010-shares-ahead-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synthetic Bio nabs U.S. patent covering lead product candidate SYN-010; shares ahead 5% premarket</a></h4><ul><li>Synthetic Biologics (NYSEMKT:<a href='https://seekingalpha.com/symbol/SYN' title='Synthetic Biologics, Inc.'>SYN</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16872476-synthetic-biologics-announces-allowance-key-u-s-patent-covering-synminus-010-intended-novel\" target=\"_blank\">announcement </a>that the USPTO has issued a Notice of Allowance for its patent application covering the use of the active agent of lead product product candidate SYN-010, its modified-release formulation of lovastatin lactone, for the treatment of constipation.</li><li>The company is preparing to launch a Phase 2b/3 pivotal trial to further assess the safety and efficacy of SYN-010.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275731\" data-linked=\"Synthetic Bio nabs U.S. patent covering lead product candidate SYN-010; shares ahead 5% premarket\" data-tweet=\"$SYN - Synthetic Bio nabs U.S. patent covering lead product candidate SYN-010; shares ahead 5% premarket https://seekingalpha.com/news/3275731-synthetic-bio-nabs-u-s-patent-covering-lead-product-candidate-synminus-010-shares-ahead-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3275731-synthetic-bio-nabs-u-s-patent-covering-lead-product-candidate-synminus-010-shares-ahead-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275722\" data-ts=\"1498569215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275722-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a>&nbsp;<font color='red'>-24%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3275714-alders-migraine-candidate-eptinezumab-successful-late-stage-study-separation-placebo\" target=\"_blank\">announcing</a> Eptinezumab Phase 3 results for prevention of frequent episodic migraine.</li><li><a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16872781-teva-xenon-announce-phase-ii-study-topical-tvminus-45070-patients-post-herpetic-neuralgia-phn\" target=\"_blank\">announcing</a> top-line results in Phase II study of topical TV-45070 in patients with post-herpetic neuralgia.</li><li><a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color='red'>-5%</font>.</li><li><a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3275662-whitehorse-finance-5-percent-capital-raise\" target=\"_blank\">announcing</a> common stock offering.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3275722\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$ALDR $XENE $AVEO - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3275722-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3275722-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275718\" data-ts=\"1498568957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275718-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275718\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$MBRX - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3275718-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3275718-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275715\" data-ts=\"1498568736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEOS\" target=\"_blank\">NEOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275715-neos-prices-equity-offering-shares-slip-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neos prices equity offering; shares slip 5% premarket</a></h4><ul><li>Thinly traded micro cap Neos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a>) is down&nbsp;<font color='red'>5%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16872930-neos-therapeutics-announces-pricing-underwritten-public-offering-32_4-million-common-stock\" target=\"_blank\">$32.4M public offering</a> of common stock at $6.75 per share (4.8M shares). Underwriters over-allotment is an additional ~726K shares. Closing date is June 30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275715\" data-linked=\"Neos prices equity offering; shares slip 5% premarket\" data-tweet=\"$NEOS - Neos prices equity offering; shares slip 5% premarket https://seekingalpha.com/news/3275715-neos-prices-equity-offering-shares-slip-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3275715-neos-prices-equity-offering-shares-slip-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275714\" data-ts=\"1498568327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDR\" target=\"_blank\">ALDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275714-alders-migraine-candidate-eptinezumab-successful-in-late-stage-study-separation-from-placebo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alder&#39;s migraine candidate eptinezumab successful in late-stage study, but separation from placebo not as significant as expected; shares down 25% premarket</a></h4><ul><li>Normally, <a href=\"https://seekingalpha.com/pr/16872526-alder-biopharmaceuticals-announces-positive-eptinezumab-phase-3-results-prevention-frequent\" target=\"_blank\">positive late-stage trial results </a>goose a stock, but not so with Alder BioPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a>). Despite a successful outcome in a Phase 3 study, PROMISE-1, assessing lead product candidate eptinezumab for migraine prevention, shares are down<font color='red'> 25%&nbsp;</font>premarket on robust volume.</li><li>The culprit appears to be a higher-than-expected placebo effect. The trial met its primary endpoint of demonstrating a statistically significant reduction in monthly migraine days from baseline in the treatment group compared to placebo, but the separation was not as profound as expected (average of 4.3 less monthly migraine days in the eptinezumab 300 mg group (p=0.0001), 3.9 days in the 100 mg cohort (p=0.0179) and 3.2 days for placebo). The baseline average was 8.6 migraine days/month so even placebo reduced the number of migraine days 37%. On average, patients receiving the highest dose of eptinezumab experienced only ~one less migraine day per month compared to placebo.</li><li>Enrollment in a second Phase 3, PROMISE 2, should be completed later this year with top-line results expected in H1 2018. If all goes well, a BLA is on tap for H2 2018.</li><li><a href=\"http://www.alderbio.com/therapeutics/pipeline/\" target=\"_blank\">Eptinezumab </a>is a monoclonal antibody that inhibits calcitonin gene-related peptide &#40;CGR&#41;, a protein involved in the transmission of, and heightened sensitivity to, migraine-related pain. It is administered via infusion once every three months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275714\" data-linked=\"Alder&#39;s migraine candidate eptinezumab successful in late-stage study, but separation from placebo not as significant as expected; shares down 25% premarket\" data-tweet=\"$ALDR - Alder&#39;s migraine candidate eptinezumab successful in late-stage study, but separation from placebo not as significant as expected; shares down 25% premarket https://seekingalpha.com/news/3275714-alders-migraine-candidate-eptinezumab-successful-in-late-stage-study-separation-from-placebo?source=tweet\" data-url=\"https://seekingalpha.com/news/3275714-alders-migraine-candidate-eptinezumab-successful-in-late-stage-study-separation-from-placebo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275709\" data-ts=\"1498567863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARR\" target=\"_blank\">ARR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275709-armour-residential-down-4_3-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Armour Residential down 4.3% on capital raise</a></h4><ul><li>If Armour Residential (NYSE:<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a>) is doing a capital raise, it might be possible that valuations are getting a bit frothy in the mortgage REIT sector.</li><li>Nevertheless,<a href=\"https://seekingalpha.com/pr/16872175-armour-residential-reit-inc-announces-public-offering-4500-000-shares-common-stock\" target=\"_blank\"> the company is selling</a> 4.5M shares. The underwriter greenshoe is for another 675K shares.</li><li>Armour closed last night at $27.48 - yes a 7% premium to March 31 book value. Bloomberg is reporting the raise as being priced at $26.40 each.</li><li>Armour is<font color='green'> up a tidy 27%</font>&nbsp;this year and&nbsp;<font color='green'>45%</font>&nbsp;Y/Y.</li><li>Shares are<font color='red'> down 4.3%</font>&nbsp;premarket to $26.30.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3275709\" data-linked=\"Armour Residential down 4.3% on capital raise\" data-tweet=\"$ARR $ARR $MORL - Armour Residential down 4.3% on capital raise https://seekingalpha.com/news/3275709-armour-residential-down-4_3-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3275709-armour-residential-down-4_3-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275700\" data-ts=\"1498566312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275700-mercks-anacetrapib-reduced-incidence-of-major-coronary-events-in-high-risk-patients-in-large\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merck&#39;s anacetrapib reduced incidence of major coronary events in high-risk patients in large-scale study; shares ahead 2% premarket</a></h4><ul><li>Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16872465-merck-provides-update-reveal-outcomes-study-anacetrapib\" target=\"_blank\">announcement </a>of positive results from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01252953?term=merck&amp;intr=anacetrapib&amp;titles=reveal&amp;rank=1\" target=\"_blank\">REVEAL</a>, assessing anacetrapib for reducing the risk of major coronary events in patients at risk for cardiac events who are currently receiving a LDL-C-lowering regimen.</li><li>The study met its primary endpoint of reducing such events compared to placebo (median follow-up of four years). The safety profile of anacetrapib was consistent with previous studies, including the accumulation of the drug in fat tissue.</li><li>The company intends to review the data with external experts and will consider global regulatory applications. Complete results will be presented at the European Society of Cardiology meeting on August 29.</li><li>Anacetrapib inhibits a protein called cholesterol ester transfer protein &#40;CETP&#41;, which is designed to elevate HDL cholesterol (the \"good\" cholesterol). CETP inhibitors were all the rage a few years ago over their potential to provide more cardioprotective benefits than lowering LDL cholesterol (the \"bad\" cholesterol). Big Pharma's efforts to push CETP inhibitors over the finish line fell flat due to toxicity and less-than-expected efficacy. Eli Lilly,&nbsp;Roche&nbsp;and Pfizer&nbsp;all abandoned their programs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275700\" data-linked=\"Merck&#39;s anacetrapib reduced incidence of major coronary events in high-risk patients in large-scale study; shares ahead 2% premarket\" data-tweet=\"$MRK - Merck&#39;s anacetrapib reduced incidence of major coronary events in high-risk patients in large-scale study; shares ahead 2% premarket https://seekingalpha.com/news/3275700-mercks-anacetrapib-reduced-incidence-of-major-coronary-events-in-high-risk-patients-in-large?source=tweet\" data-url=\"https://seekingalpha.com/news/3275700-mercks-anacetrapib-reduced-incidence-of-major-coronary-events-in-high-risk-patients-in-large\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275695\" data-ts=\"1498565863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275695-j-c-penney-on-move-after-gordon-haskett-bump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney on the move after Gordon Haskett bump</a></h4><ul> <li>Gorden Haskett Research Advisors upgrades J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) to a Hold rating after having it set at Reduce.</li> <li>The firm thinks J.C. Penney will be able to hit its guidance for -1% to +1% FY17 same-store sales growth as its new mix of merchandise contributes.</li> <li>JCP <font color='green'>+1.93%</font> premarket to $4.76.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3275695\" data-linked=\"J.C. Penney on the move after Gordon Haskett bump\" data-tweet=\"$JCP - J.C. Penney on the move after Gordon Haskett bump https://seekingalpha.com/news/3275695-j-c-penney-on-move-after-gordon-haskett-bump?source=tweet\" data-url=\"https://seekingalpha.com/news/3275695-j-c-penney-on-move-after-gordon-haskett-bump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275678\" data-ts=\"1498564485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275678-sprintplus-3_5-on-report-of-talks-over-wireless-deal-t-mobile-usminus-3_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint +3.5% on report of talks over wireless deal; T-Mobile US -3.4%</a></h4><ul>     <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) <font color='green'>+3.5%</font> and T-Mobile US&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) <font color='red'>-3.4%</font> premarket following last night's <em>WSJ</em> report that Sprint is in discussions with Charter (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) and Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) about a <a href=\"https://seekingalpha.com/news/3275622-wsj-sprint-exploring-wireless-deal-charter-comcast\" target=\"_blank\">possible wireless deal</a>.</li>     <li>According to the report, Sprint has entered talks with Charter and Comcast for a network resale deal that would allow the cable companies to offer wireless services to their customers and perhaps even take an equity stake in Sprint; the reported discussions would put Sprint's merger talks with T-Mobile US on hold until at least the end of July.</li><li>Also: CHTR <font color='green'>+0.3%</font>, CMCSA <font color='red'>-1.5%</font> premarket; Deutsche Telekom (<a href='https://seekingalpha.com/symbol/DTEGY' title='Deutsche Telekom AG ADR'>OTCQX:DTEGY</a>) <font color='red'>-2.4%</font> in Frankfurt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275678\" data-linked=\"Sprint +3.5% on report of talks over wireless deal; T-Mobile US -3.4%\" data-tweet=\"$S $S $TMUS - Sprint +3.5% on report of talks over wireless deal; T-Mobile US -3.4% https://seekingalpha.com/news/3275678-sprintplus-3_5-on-report-of-talks-over-wireless-deal-t-mobile-usminus-3_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3275678-sprintplus-3_5-on-report-of-talks-over-wireless-deal-t-mobile-usminus-3_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275662\" data-ts=\"1498563025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHF\" target=\"_blank\">WHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275662-whitehorse-finance-down-5-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whitehorse Finance down more than 5% on capital raise</a></h4><ul><li>The hot-handed Whitehorse Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a>)&nbsp;is selling&nbsp;<a href=\"https://seekingalpha.com/pr/16872194-whitehorse-finance-inc-announces-offering-common-stock\" target=\"_blank\">2.5M shares</a>. The underwriter greenshoe is for another 375K shares, with that stock looking like it would be coming from two shareholders, not the company.</li><li>Whitehorse reported NAV per share of $13.80 as of March 31 vs. last night's close of $14.37. Bloomberg reports the shares as being offered at $13.97 each.</li><li>Shares<font color='red'> -5.5%</font>&nbsp;premarket to $13.58.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275662\" data-linked=\"Whitehorse Finance down more than 5% on capital raise\" data-tweet=\"$WHF - Whitehorse Finance down more than 5% on capital raise https://seekingalpha.com/news/3275662-whitehorse-finance-down-5-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3275662-whitehorse-finance-down-5-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3275660\" data-ts=\"1498562641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBI\" target=\"_blank\">MBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3275660-downgrade-of-mbias-national-sparks-rally-sale-mulled\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Downgrade of MBIA&#39;s National sparks rally as sale mulled</a></h4><ul><li>S&amp;P yesterday afternoon downgraded MBIA's (NYSE:<a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a>) municipal bond insurance unit by two notches to A from AA-. The move, <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=iffbk-b\" target=\"_blank\">says BTIG bull Mark Palmer</a>, significantly diminishes National's ability to write new business, and thus boosts the chances that MBIA will look to sell itself.</li><li>The natural buyer, says Palmer, is Assured Guaranty (NYSE:<a href='https://seekingalpha.com/symbol/AGO' title='Assured Guaranty Ltd.'>AGO</a>), which has been clear about its intention to consolidate what's left of the monoline industry.</li><li>He reiterates his Buy rating and $14 price target. That's 50% of adjusted book value, and nearly<font color='green'> 60% upside</font>&nbsp;for the stock.</li><li>MBIA gained<font color='green'> 4.6%</font>&nbsp;yesterday, and Assured Guaranty&nbsp;<font color='green'>2.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3275660\" data-linked=\"Downgrade of MBIA&#39;s National sparks rally as sale mulled\" data-tweet=\"$MBI $MBI $AGO - Downgrade of MBIA&#39;s National sparks rally as sale mulled https://seekingalpha.com/news/3275660-downgrade-of-mbias-national-sparks-rally-sale-mulled?source=tweet\" data-url=\"https://seekingalpha.com/news/3275660-downgrade-of-mbias-national-sparks-rally-sale-mulled\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":60,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}